Transcenta Holding Limited (HKG:6628)
Hong Kong · Delayed Price · Currency is HKD
2.220
+0.110 (5.21%)
At close: Mar 6, 2026
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
The Discovering, Developing, Manufacturing and Commercializing Novel Drugs | 11.26M | 53.85M | 101.89M | 50.24M | 80.98M | |
The Discovering, Developing, Manufacturing and Commercializing Novel Drugs Growth | -79.09% | -47.15% | 102.80% | -37.96% | 83.46% | |
| 11.26M | 53.85M | 101.89M | 50.24M | 80.98M | |
| -79.09% | -47.15% | 102.80% | -37.96% | 83.46% | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 11.26M | 53.85M | 101.89M | 50.24M | 80.98M | |
| -79.09% | -47.15% | 102.80% | -37.96% | 83.46% | |
| 11.26M | 53.85M | 101.89M | 50.24M | 80.98M | |
| -79.09% | -47.15% | 102.80% | -37.96% | 83.46% | |
Source: S&P Global Market Intelligence.
